You are here
Uma Devi Goyal, MD
Uma Devi Goyal, MD
Dr. Goyal earned her medical degree from the University of Arizona where she graduated with research distinction. She received her dual undergraduate degrees with honors from the University of Arizona. After completing her internship in internal medicine at Loma Linda University in Loma Linda, CA, she trained in Radiation Oncology at the University of Arizona-Banner Medical Center. Dr. Goyal is Assistant Professor at the University of Arizona, Department of Radiation Oncology, and a member of the University of Arizona Cancer Center. She specializes in treating patients with gastrointestinal cancer, sarcoma and metastatic cancer.
American Society of Radiation Oncology
American Society of Clinical Oncology
American Brachytherapy Society
Arizona Medical Board
Dr. Goyal specializes in GI and sarcoma radiotherapy and works closely with the multidisciplinary GI and sarcoma cancer treatment teams. She employs numerous different treatment techniques to best adapt therapy to suit individual patient needs. These include external beam radiotherapy as well as brachytherapy with high dose rate (HDR) radiation.
Dr. Goyal has published research in peer-reviewed journals and has presented data at national research conferences. Her research includes investigation of novel techniques of shielding normal organs during prone whole breast radiotherapy and she recently was one of the primary investigators on a prospective trial investigating methods for improving heart dose during breast radiotherapy. She also was a recipient of a Better than Ever grant for her research on immobilization balloons for tandem and ovoid brachytherapy for cervical cancer. Her current areas of interest include advanced treatment modalities for radiation therapy and potential biomarkers to improve radiation therapy outcomes. Dr. Goyal is a member of the American Society of Radiation Oncology, the American Society of Clinical Oncology, and the American Brachytherapy Society.
Goyal U, Pan J, Cui H, Stea B. Does ultrasound measurement improve the accuracy of electronic brachytherapy in the treatment of superficial non-melanomatous skin cancer? J Contemp Brachytherapy. 2017 Feb;9(1):14-19. doi: 10.5114/jcb.2017.65476.
Prabhakar N*, Goyal U*, Gonzalez VJ. Irinotecan-induced radiation-recall myositis in a patient with metastatic breast cancer: A case report. Pract Radiat Oncol. 2017 Jan 20. pii: S1879-8500(17)30010-3. doi: 10.1016/j.prro.2017.01.010. *co-first authors
Slane BG*, Goyal U*, Grow JL, Morrison C, Hullett CR, Gordon J, Sanan A, Stea B. Radiotherapeutic management of vestibular schwannomas using size- and location-adapted fractionation regimens to maximize the therapeutic ratio. Pract Radiat Oncol. 2017 May - Jun;7(3):e233-e241. doi: 10.1016/j.prro.2016.10.016. *co-first authors
Goyal U, Locke A, Smith-Raymond L, Georgiev GN. Simple shielding reduces dose to the contralateral breast during prone breast cancer radiotherapy. Med Dosim. 2016 Summer;41(2):159-65. doi: 10.1016/j.meddos.2015.12.001.
Better than Ever 2015
SELECTED MEETING PRESENTATIONS
Prone Positioning with Deep Inspiration Breath Hold for Left Breast Radiotherapy: Initial Results of a Prospective Study. American Society for Radiation Oncology 2016.
Prospective Study of Non-Randomized Intervention Based on Review of Edmonton Symptom Assessment Scales vs Routine Symptom Management During Weekly On-Treatment Visits. American Society for Radiation Oncology 2016.
Immobilization Balloons Used for Specialized Brachytherapy Treatments for Cervical Cancer Patients. American Brachytherapy Society 2016.
Intensity Modulated Proton Therapy for Retreatment of Colorectal and Anal Cancer. Particle Therapy Co-Operative Group 2016.
Intensity Modulated Proton Therapy for Retreatment of CNS and H&N Tumors. Particle Therapy Co-Operative Group 2016.
Role Of Concurrent Systemic Therapy With Adjuvant Radiation Therapy For Locally Advanced Cutaneous Squamous Cell Carcinoma. American Radium Society 2016.